Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • MS experts of the future

New Master’s Program “Multiple Sclerosis Management” launched

    • Education
    • Neurology
    • News
    • Prevention and health care
    • RX
  • 2 minute read

Medicine and its training are constantly evolving and adapting to new realities. Because multiple sclerosis is a disease with a thousand faces, there is a high demand for specialized professionals. The new master’s program in Dresden (D) now does justice to this. The program provides in-service training for specialists and managers in the healthcare sector.

Multiple sclerosis (MS) affects approximately 10,000 people in Switzerland and is currently considered incurable. The consequences include muscle weakness, paralysis, reduction of the optic nerves or a spasmodic increase in muscle tension. The course of the disease is individual for each patient, which is why it is known as the “disease of a thousand faces”. Early diagnosis and therapy are crucial for the further course of the disease. Individually adapted therapy options make patients’ lives easier and inhibit the process of the disease. Treatment is lifelong and very complex. Therefore, the need for trained and specialized forces is high. In October, the unique master’s program “Multiple Sclerosis Management” started at Dresden International University (DIU). The continuing education program is designed for physicians, therapists, scientists, psychologists, pharmacists, biologists or nurses who wish to specialize in MS. The prerequisite is a degree in human medicine or a related field with a total of 240 ECTS credits. Furthermore, individuals with an initial academic degree who have completed training in a health profession and one year of professional work in the field of MS may enter the master’s program. After successful completion, they receive the title “Master of Science” (M.Sc.). The part-time course of study is spread over four semesters and is held primarily in online seminars. In addition, practical units are offered, for which we have selected centers with great experience in diagnostics and therapy. The course is divided into the modules “Theoretical Foundations”, “Clinic and Diagnostics”, “Studies and Statistics”, “Therapy and Rehabilitation”, “Monitoring and Documentation” on MS and other neuroimmunological diseases. The prospective experts learn detailed and scientifically based diagnostics and differential diagnostics for suspected chronic inflammatory diseases of the central nervous system. They are supported by renowned specialists from Germany, Austria and Switzerland. After successful introduction of the new degree program, internationalization is planned.

Source: “New Master’s Program “Multiple Sclerosis Management” Sets the Course in Medicine”, 29.09.2020, Dresden International University (DIU).

 

InFo NEUROLOGY & PSYCHIATRY 2020; 18(6): 48.

Autoren
  • Leoni Burggraf
Publikation
  • InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
  • MS
  • Multiple sclerosis
  • Study
  • training
Previous Article
  • Digitalization of rheumatology

Rheumatism apps as diagnostic aids

  • Education
  • General Internal Medicine
  • Geriatrics
  • Prevention and health care
  • Rheumatology
  • RX
View Post
Next Article
  • Acne vulgaris

Acne – new insights into the role of the skin microbiome

  • Congress Reports
  • Dermatology and venereology
  • Infectiology
  • RX
View Post
You May Also Like
View Post
  • 4 min
  • From symptom to diagnosis

Pneumology – tracheal and bronchial calcifications

    • RX
    • Cases
    • Education
    • General Internal Medicine
    • Pneumology
    • Radiology
View Post
  • 3 min
  • Tinea capitis: Current Guidelines and Recommendations

What should be kept in mind when treating adult patients?

    • Dermatology and venereology
    • Education
    • Infectiology
    • Pharmacology and toxicology
    • RX
View Post
  • 7 min
  • Geriatric patients

Micronutrient Intake in Older Adults

    • RX
    • Education
    • General Internal Medicine
    • Geriatrics
    • Nutrition
View Post
  • 7 min
  • Crohn's disease: focus on long-term results

“Top-down” approach or classic step therapy?

    • RX
    • Congress Reports
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Studies
View Post
  • 4 min
  • SwissDiab Study: New Analysis Published

How are diabetes complications associated with quality of life?

    • RX
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Studies
View Post
  • 6 min
  • Pre-acclimatization on Mount Everest

Exploring the physiological limits

    • RX
    • Congress Reports
    • General Internal Medicine
    • Pneumology
    • Studies
    • Tropical and travel medicine
View Post
  • 5 min
  • Viloxazine for ADHD

A non-stimulating option—but with limited evidence

    • RX
    • Education
    • Neurology
    • Pediatrics
    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • Studies
View Post
  • 6 min
  • Preclinical study on phytotherapeutic agent

Active ingredient combination of peppermint and caraway oil modified fecal microbiota

    • RX
    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Pharmaceutical medicine
    • Phytotherapy
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Current State of Knowledge and New Therapeutic Approaches
  • 2
    Why is it so hard to lose weight?
  • 3
    Functional limb preservation between infection control, vascular medicine and resurfacing
  • 4
    Algorithms, avatars and the unburdened mind
  • 5
    Communication as the key to therapy adherence

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.